Nephrotoxicity was more marked in rats receiving isepamicin at midlight than at middark. And, the once-daily administration at middark induced a lesser degree of nephrotoxicity than the twice-daily injection, which indicates that the once-daily treatment therapy may have potential value in the clinical use of aminoglycosides.
No takes yet. Share an insight, caveat, or question.
Yoshiyama et al. (1993) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: